Roquefort Therapeutics PLC on Thursday said it has proposed the sale of subsidiary Lyramid Pty Ltd to Pleiades Pharma ...
Roquefort Therapeutics PLC 02 January 2025 2 January 2025 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Proposed Sale of Midkine Portfolio Roquefort Therapeutics...
Roquefort Therapeutics PLC 04 December 2024 4 December 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Director Share Distribution Roquefort Therapeutics...
Roquefort Therapeutics PLC 07 November 2024 7 November 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Conversion of Convertible Loan Notes Roquefort...
Roquefort Therapeutics PLC 06 November 2024 6 November 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") STAT-6 siRNA Presentation at Advanced Therapy Development...
The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by ...
Roquefort Therapeutics PLC 27 September 2024 27 September 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Interim Results to 30 June 2024 Roquefort...
Roquefort Therapeutics PLC on Monday announced its patent for mesodermal killer, or MK, cell therapy has been approve ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.13 | 3.20987654321 | 4.05 | 5 | 3.9 | 1551634 | 4.13536455 | DE |
4 | 0.03 | 0.722891566265 | 4.15 | 5 | 3.8 | 1020852 | 4.19371313 | DE |
12 | 0.23 | 5.82278481013 | 3.95 | 6.75 | 3.6 | 1522780 | 4.64191828 | DE |
26 | -0.57 | -12 | 4.75 | 6.75 | 3.35 | 833542 | 4.53380493 | DE |
52 | -3.07 | -42.3448275862 | 7.25 | 9.25 | 3.35 | 561255 | 4.75810797 | DE |
156 | -6.32 | -60.1904761905 | 10.5 | 11.25 | 3.35 | 368933 | 6.43966031 | DE |
260 | -1.82 | -30.3333333333 | 6 | 13.5 | 3.35 | 302631 | 6.55085003 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.